ChemicalBook > Product Catalog >API >Circulatory system drugs >Antiarrhythmics Drugs >Carteolol hydrochloride

Carteolol hydrochloride

Carteolol hydrochloride Structure
CAS No.
51781-21-6
Chemical Name:
Carteolol hydrochloride
Synonyms
endak;oc1085;Teoptic;Tenalet;Cartrol;Carteol;Cartelo;mikelan;opc1085;Cartelol
CBNumber:
CB6335371
Molecular Formula:
C16H25ClN2O3
Molecular Weight:
328.83
MOL File:
51781-21-6.mol
Modify Date:
2024/7/2 8:55:14

Carteolol hydrochloride Properties

Melting point 278°C
storage temp. Refrigerator
solubility Soluble in water, sparingly soluble in methanol, slightly soluble in ethanol 96 per cent, practically insoluble in methylene chloride.
form Solid
color White to Off-White
Merck 14,1866

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P301+P312+P330
RTECS  VC8282000
HS Code  2933790002
Toxicity LD50 in male mice, rats (mg/kg): 810, 1380 orally; 54.5, 158 i.v.; 380, 400 i.p. (Lang)
NFPA 704
0
2 0

Carteolol hydrochloride Chemical Properties,Uses,Production

Chemical Properties

Crystalline Solid

brand name

Cartrol (Abbott); Ocupress (Novartis).

Pharmacology

Carteolol hydrochloride is a powerful beta-adrenergic receptor antagonist characterized by a long-term pharmacological action, the lack of beta receptor selectivity, an intrinsic sympathomimetic activity (ISA), and a slight local anaesthetic activity (approximately 1/10 of that of propranolol). This drug has a dose-dependent hypotensive effect and does not engender the onset of tachyphylaxis. The pharmacological action consists in the decreased formation of aqueous humor, probably by acting at the level of the ciliary body presenting a wealth of ?2 receptors. The intrinsic sympathomimetic activity of carteolol is responsible for the low incidence of side effects and, thus, for maintaining the heart rate, pulse rate, and arterial blood pressure within the normal physiological range.

Pharmacokinetics

The instillation of carteolol hydrochloride is followed by the rapid absorption by the ocular tissues. Following the instillation of 10μl of 14C-carteolol ophthalmic solution 20 mg/ml into rabbit eyes, the highest platelet and tissue concentrations were obtained between 30 minutes to 2 hours. The study shows that, following topical application, carteolol spreads rapidly into the ocular tissues, passing the corneal barrier. The highest concentrations of 14C-carteolol were found in the following ocular tissues: cornea, iris, anterior sclera, ciliary body conjunctiva, and extraocular muscle. Slightly lower concentrations were found in the retina, choroid, posterior sclera, optic nerve, and aqueous humor. The concentration was especially low in the lens, vitreous body, and plasma. In the various tissues of the contralateral eye, very low radioactivity levels were measured. After the instillation of one drop of carteolol ophthalmic solution 20 mg/ml in healthy volunteers, the plasma concentrations were negligible (1-2 ng/ml). Approximately 16% of the dose is excreted in the urine as an unchanged compound during the first 24 hours after the instillation of a single drop of carteolol hydrochloride 20 mg/ml. The urinary elimination half-life following topical application is about 5 hours.

Clinical Use

The chemical name for carteolol hydrochloride (carteolol) is (±)-5-[3-[(1,1-dimethyl ethyl) amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone monohydrochloride. Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adrenoceptor blocking agent for ophthalmic use. Each mL of sterile solution contains Active: carteolol hydrochloride (carteolol) 10 mg (1%). This drug is used to treat open-angle glaucoma and other causes of high pressure inside the eye. Carteolol hydrochloride ophthalmic may interact with oral carteolol, digoxin, reserpine, insulin or oral diabetes medications, other beta-blockers, calcium channel blockers, or medicines to treat psychiatric disorders.

Carteolol hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 183)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
STELLENCE PHARMSCIENCE PVT TLD +91-9820778787 +91-9820778787 Bangalore, India 25 58 Inquiry
CNS CHEMICALS +91-9381957258 +91-9381957258 Telangana, India 354 58 Inquiry
EDMOND PHARMA New Delhi, India 5 58 Inquiry
TCI Chemicals (India) Pvt. Ltd. 1800 425 7889 New Delhi, India 6778 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Stellence Pharmscience Private Limited 08068970604Ext 488 Karnataka, India 22 58 Inquiry
Cns Chemicals 08066085913Ext 735 Hyderabad, India 262 58 Inquiry
Kebee Pharmachemie Pvt., Ltd. 91-22-28328669 Maharashtra, India 65 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry

Carteolol hydrochloride Spectrum

5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone Hydrochloride 5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone monohydrochloride Arteoptic Caltidren Carteol Cartrol dl-Carteolol hydrochloride NSC 300906 Optipress Tenalet Teoptic Cartelo Cartelol Carteolol T Orukalol Carteolol Hydrochloride (200 mg) Ocupress 2(1H)-Quinolinone,5-[3-[(1,1-diMethylethyl)aMino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride(1:1) 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone,hydrochloride (1:1) Carteolol monohydrochloride 5-(2-hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyrilhydrochloride 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2(1h)-quinolin 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyrilhydrochloride 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1h)-chinolinon-hydroch abbott-43326 carbonolol carteololhydrochloride endak endakmite mikelan oc1085 opc1085 2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE carteolol HCl CARTEOLOL (HYDROCHLORIDE);NSC 300906;OPC 1085 Carteolol for system suitability CRS OPC-1085 hydrochloride 5-[(2RS)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]- 3,4-dihydroquinolin-2(1H)-one hydrochloride Carteolol hydrochloride USP/EP/BP Carteolol HCl (OPC-1085 HCl) 2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE 51781-21-6 Carteolol Hydrochloride (1096757) Carteolol Hydrochloride CAS NO.51781-21-6 51781-21-6 C16H25ClN2O3 C16H24N2O3HCl 32883 CARTROL Intermediates & Fine Chemicals Pharmaceuticals API